ScreenAct
ScreenACT, founded in 2021 in the Auvergne-Rhône-Alpes region, is a clinical research technology company that provides a comprehensive web application platform aggregating reliable data sources such as NIH and others to offer the most complete clinical trials database and the most efficient screening tool on the market. Their platform enables quick identification of clinical trials, research center activities, and direct connections with trial sponsors and investigators, facilitating patient matching and decentralization of clinical trials. ScreenACT offers premium subscription services with advanced features including detailed screenings, activity analyses, and access to European clinical trial data. The company also provides specialized services for pharmaceutical and biotech companies, including investigator site selection, competitive analysis, and custom feature development. ScreenACT has received multiple innovation awards and is recognized as a top innovative oncology solution in Europe, positioning itself as a key player in accelerating patient inclusion and access to innovative therapies in clinical research.
ScreenAct
ScreenACT, founded in 2021 in the Auvergne-Rhône-Alpes region, is a clinical research technology company that provides a comprehensive web application platform aggregating reliable data sources such as NIH and others to offer the most complete clinical trials database and the most efficient screening tool on the market. Their platform enables quick identification of clinical trials, research center activities, and direct connections with trial sponsors and investigators, facilitating patient matching and decentralization of clinical trials. ScreenACT offers premium subscription services with advanced features including detailed screenings, activity analyses, and access to European clinical trial data. The company also provides specialized services for pharmaceutical and biotech companies, including investigator site selection, competitive analysis, and custom feature development. ScreenACT has received multiple innovation awards and is recognized as a top innovative oncology solution in Europe, positioning itself as a key player in accelerating patient inclusion and access to innovative therapies in clinical research.